OSTX OS Therapies Incorporated
$1.68▼ -7.69%
Healthcare
Other
After hours
$1.68▲ +0.00%
Sep 11, 7:24 PM ET
Volume 823.0K
Avg Volume (10D) 654.8K
Key Metrics & Fundamentals
Market Cap
$78.07M
P/E Ratio
–
Div Yield
–%
52W Range
1.15 - 2.32
% vs 50 MA
3.92%
% vs 200 MA
5.82%
RSI-14
49.7
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.68
Free Cash Flow
-$5.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$8.50M
COGS
–
Operating Exp
$8.58M
Operating Income
-$8.58M
EBIT
-$8.58M
Pretax Income
-$8.63M
Net Income
-$8.63M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
OS Therapies Achieves Statistically Significant Benefit for OST-HER2-Treated Patients in Interim 3-Year Overall Survival Analysis of Phase 2b Pulmonary Metastatic Osteosarcoma Trial
TMX Newsfile · Sep 8, 2026 10:00 AM
OS Therapies Provides OST-HER2 Metastatic Osteosarcoma Program Update and Announces Upcoming Conference Attendance
TMX Newsfile · Sep 2, 2026 11:20 AM
OS Therapies Reports Second Quarter 2026 Financials and Provides Business and Regulatory Updates
TMX Newsfile · Aug 17, 2026 11:40 AM
OS Therapies Granted U.S. FDA Type C Statistical Methods Meeting to Review 2.5-Year Overall Survival Data for OST-HER2 in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma
TMX Newsfile · Aug 13, 2026 12:45 PM
OS Therapies Accepts New FDA Meeting Request to Review Biomarker Data as Part of BEST Program
TMX Newsfile · Jul 8, 2026 1:00 PM
OS Therapies Third Quarter 2026 Corporate Outlook
TMX Newsfile · Jul 6, 2026 1:00 PM
OS Therapies Appoints Dr. Craig Eagle to Board of Directors
TMX Newsfile · Jul 2, 2026 11:30 AM
OS Therapies Provides U.S. Regulatory Update
TMX Newsfile · Jun 30, 2026 11:40 AM
OS Animal Health Announces Peer-Reviewed Publication of Clinical Trial Data for OST-HER2 Plus Palliative Radiation as Frontline Treatment in Canine Osteosarcoma
TMX Newsfile · Jun 26, 2026 11:40 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See OSTX's money flow as a full page
Social Sentiment
Avg +0.90 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.